Jiangsu Topcel-kh Pharmaceutical Co., Ltd.
Clinical trials sponsored by Jiangsu Topcel-kh Pharmaceutical Co., Ltd., explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Armored cells take on tough lymphoma in early trial Results expected Jan 2027 (estimated)
- New CAR-T therapy targets lymphoma that escapes standard treatment Results expected Jan 2027 (estimated)
- Stem cell shot may keep dialysis lifeline open for kidney patients Results expected Mar 2027 (estimated)